The company receives financial aid of 425 k€ (PIA / BPI) for the continuation of its ALDESCREEN project.
Advanced BioDesign will receive a total of €425,604 in funding to support the development of its ALDESCREEN project over the next three years.
The ALDESCREEN project aims to develop an early diagnostic test for lung cancer that will allow a more accurate targeting of patients and cancer therapies.